BiTE is an artificial antibody with two antigen-binding sites, one binding to the CD3 molecule on the T cell and the other binding to a specific antigen on the tumor cell, thereby bringing the T cells and the tumor cells together and activating the killing function of the T cells (57). Here, CEP70 is linked to neoplasm.